Experts at the CDC publicly discussed the fate of the Johnson & Johnson vaccine. This is because it is associated with a deadly but rare adverse reaction. Banning the drug was on the table, but they settled on a preferential recommendation.
Experts at the CDC publicly discussed the fate of the Johnson & Johnson vaccine. This is because it is associated with a deadly but rare adverse reaction. Banning the drug was on the table, but they settled on a preferential recommendation.